The article reports that the Dublin, Ireland-based medical device manufacturer Medtronic Inc. has broadened the scope of its diabetes treatment business with its new deals. It states that they announced several business developments including collaboration with Watson Health, investment in DreaMed Diabetes, and acquisition of care clinic Diabeter. It mentions that they licensed the Glucositter algorithm.